{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:40Z","timestamp":1793911300273,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation in myocarditis induces cardiac injury and triggers disease progression to heart failure. NLRP3 inflammasome activation is a newly identified amplifying step in the pathogenesis of myocarditis. We previously have demonstrated that mesenchymal stromal cells (MSC) are cardioprotective in Coxsackievirus B3 (CVB3)-induced myocarditis. In this study, MSC markedly inhibited left ventricular (LV) NOD2, NLRP3, ASC, caspase-1, IL-1\u03b2, and IL-18 mRNA expression in CVB3-infected mice. ASC protein expression, essential for NLRP3 inflammasome assembly, increased upon CVB3 infection and was abrogated in MSC-treated mice. Concomitantly, CVB3 infection<jats:italic>in vitro<\/jats:italic>induced NOD2 expression, NLRP3 inflammasome activation and IL-1\u03b2 secretion in HL-1 cells, which was abolished after MSC supplementation. The inhibitory effect of MSC on NLRP3 inflammasome activity in HL-1 cells was partly mediated via secretion of the anti-oxidative protein stanniocalcin-1. Furthermore, MSC application in CVB3-infected mice reduced the percentage of NOD2-, ASC-, p10- and\/or IL-1\u03b2-positive splenic macrophages, natural killer cells, and dendritic cells. The suppressive effect of MSC on inflammasome activation was associated with normalized expression of prominent regulators of myocardial contractility and fibrosis to levels comparable to control mice. In conclusion, MSC treatment in myocarditis could be a promising strategy limiting the adverse consequences of cardiac and systemic NLRP3 inflammasome activation.<\/jats:p>","DOI":"10.1038\/s41598-018-20686-6","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T11:23:08Z","timestamp":1517916188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy"],"prefix":"10.1038","volume":"8","author":[{"given":"Kapka","family":"Miteva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Pappritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Sosnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"El-Shafeey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengquan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Savvatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tsch\u00f6pe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Van Linthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"issue":"2636\u20132648","key":"20686_CR1","first-page":"2648a","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio, A. L. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 34(2636\u20132648), 2648a\u20132648d (2013).","journal-title":"Eur Heart J."},{"key":"20686_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr.","year":"2002","unstructured":"Janeway, C. A. Jr. & Medzhitov, R. Innate immune recognition. Annu Rev Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu Rev Immunol."},{"key":"20686_CR3","doi-asserted-by":"crossref","unstructured":"M\u00fcller, I. et al. Pathogenic role of the damage-associated molecular patterns S100A8 and S100A9 in Coxsackievirus B3-induced myocarditis. Circ Heart Fail.; In Press (2017).","DOI":"10.1161\/CIRCHEARTFAILURE.117.004125"},{"key":"20686_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/nyas.12458","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala, F. S., Haasken, S. & Cassel, S. L. Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 1319, 82\u201395 (2014).","journal-title":"Ann N Y Acad Sci."},{"key":"20686_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/ni.1782","volume":"10","author":"A Sabbah","year":"2009","unstructured":"Sabbah, A. et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol. 10, 1073\u20131080 (2009).","journal-title":"Nat Immunol."},{"key":"20686_CR6","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1159\/000356618","volume":"32","author":"X Li","year":"2013","unstructured":"Li, X. et al. NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice. Cell Physiol Biochem. 32, 1857\u20131866 (2013).","journal-title":"Cell Physiol Biochem."},{"key":"20686_CR7","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","volume":"128","author":"BW Van Tassell","year":"2013","unstructured":"Van Tassell, B. W., Toldo, S., Mezzaroma, E. & Abbate, A. Targeting interleukin-1 in heart disease. Circulation. 128, 1910\u20131923 (2013).","journal-title":"Circulation."},{"key":"20686_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/01.RES.81.4.493","volume":"81","author":"CF McTiernan","year":"1997","unstructured":"McTiernan, C. F. et al. Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res. 81, 493\u2013503 (1997).","journal-title":"Circ Res."},{"key":"20686_CR9","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1073\/pnas.041611398","volume":"98","author":"BJ Pomerantz","year":"2001","unstructured":"Pomerantz, B. J., Reznikov, L. L., Harken, A. H. & Dinarello, C. A. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta. Proc Natl Acad Sci USA 98, 2871\u20132876 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"20686_CR10","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/CIRCULATIONAHA.107.740233","volume":"117","author":"A Abbate","year":"2008","unstructured":"Abbate, A. et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 117, 2670\u20132683 (2008).","journal-title":"Circulation."},{"key":"20686_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","volume":"123","author":"M Kawaguchi","year":"2011","unstructured":"Kawaguchi, M. et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury. Circulation. 123, 594\u2013604 (2011).","journal-title":"Circulation."},{"key":"20686_CR12","doi-asserted-by":"publisher","first-page":"H1438","DOI":"10.1152\/ajpheart.00441.2014","volume":"307","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Gao, B. & Xiong, S. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. Am J Physiol Heart Circ Physiol. 307, H1438\u20131447 (2014).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"20686_CR13","doi-asserted-by":"crossref","unstructured":"Tschope, C. et al. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis. Circ Heart Fail. 10 (2017).","DOI":"10.1161\/CIRCHEARTFAILURE.117.003870"},{"key":"20686_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 377, 1119\u20131131 (2017).","journal-title":"N Engl J Med."},{"key":"20686_CR15","doi-asserted-by":"publisher","first-page":"353097","DOI":"10.1155\/2013\/353097","volume":"2013","author":"K Miteva","year":"2013","unstructured":"Miteva, K., Van Linthout, S., Volk, H. D. & Tschope, C. Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Stem Cells Int. 2013, 353097 (2013).","journal-title":"Stem Cells Int."},{"key":"20686_CR16","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.2174\/138161211797904136","volume":"17","author":"C Tschope","year":"2011","unstructured":"Tschope, C., Miteva, K., Schultheiss, H. P. & Linthout, S. V. Mesenchymal stromal cells: a promising cell source for the treatment of inflammatory cardiomyopathy. Curr Pharm Des. 17, 3295\u20133307 (2011).","journal-title":"Curr Pharm Des."},{"key":"20686_CR17","doi-asserted-by":"crossref","unstructured":"Van Linthout, S. et al. Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance. Stem Cells Transl Med (2017).","DOI":"10.1002\/sctm.17-0130"},{"key":"20686_CR18","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/eurheartj\/ehq467","volume":"32","author":"S Van Linthout","year":"2011","unstructured":"Van Linthout, S. et al. Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis. Eur Heart J. 32, 2168\u20132178 (2011).","journal-title":"Eur Heart J."},{"key":"20686_CR19","doi-asserted-by":"publisher","first-page":"e41047","DOI":"10.1371\/journal.pone.0041047","volume":"7","author":"K Savvatis","year":"2012","unstructured":"Savvatis, K. et al. Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. PLOS One. 7, e41047 (2012).","journal-title":"PLOS One."},{"key":"20686_CR20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/stem.1608","volume":"32","author":"JY Oh","year":"2014","unstructured":"Oh, J. Y. et al. Mesenchymal stem\/stromal cells inhibit the NLRP3 inflammasome by decreasing mitochondrial reactive oxygen species. Stem Cells. 32, 1553\u20131563 (2014).","journal-title":"Stem Cells."},{"key":"20686_CR21","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/eji.200940168","volume":"40","author":"F Martinon","year":"2010","unstructured":"Martinon, F. Signaling by ROS drives inflammasome activation. Eur J Immunol. 40, 616\u2013619 (2010).","journal-title":"Eur J Immunol."},{"key":"20686_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1161\/01.ATV.0000140061.89096.2b","volume":"24","author":"O Hofnagel","year":"2004","unstructured":"Hofnagel, O. et al. Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 24, 1789\u20131795 (2004).","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"20686_CR23","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/j.ijcard.2013.12.137","volume":"171","author":"S Toldo","year":"2014","unstructured":"Toldo, S. et al. Formation of the inflammasome in acute myocarditis. Int J Cardiol. 171, e119\u2013121 (2014).","journal-title":"Int J Cardiol."},{"key":"20686_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U Kuhl","year":"2005","unstructured":"Kuhl, U. et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation. 111, 887\u2013893 (2005).","journal-title":"Circulation."},{"key":"20686_CR25","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","volume":"112","author":"U Kuhl","year":"2005","unstructured":"Kuhl, U. et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation. 112, 1965\u20131970 (2005).","journal-title":"Circulation."},{"key":"20686_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.acvd.2009.04.010","volume":"102","author":"L Andreoletti","year":"2009","unstructured":"Andreoletti, L. et al. Viral causes of human myocarditis. Arch Cardiovasc Dis. 102, 559\u2013568 (2009).","journal-title":"Arch Cardiovasc Dis."},{"key":"20686_CR27","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1073\/pnas.1108586108","volume":"108","author":"E Mezzaroma","year":"2011","unstructured":"Mezzaroma, E. et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci USA 108, 19725\u201319730 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"20686_CR28","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/intimm\/dxq058","volume":"22","author":"M Lech","year":"2010","unstructured":"Lech, M. et al. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol. 22, 717\u2013728 (2010).","journal-title":"Int Immunol."},{"key":"20686_CR29","doi-asserted-by":"publisher","first-page":"8014","DOI":"10.1128\/JVI.79.13.8014-8023.2005","volume":"79","author":"X Si","year":"2005","unstructured":"Si, X. et al. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol. 79, 8014\u20138023 (2005).","journal-title":"J Virol."},{"key":"20686_CR30","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/01.CIR.102.18.2276","volume":"102","author":"C Badorff","year":"2000","unstructured":"Badorff, C. et al. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation. 102, 2276\u20132281 (2000).","journal-title":"Circulation."},{"key":"20686_CR31","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1002\/eji.200526286","volume":"35","author":"JH Fritz","year":"2005","unstructured":"Fritz, J. H. et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol. 35, 2459\u20132470 (2005).","journal-title":"Eur J Immunol."},{"key":"20686_CR32","doi-asserted-by":"publisher","first-page":"e36734","DOI":"10.1371\/journal.pone.0036734","volume":"7","author":"F Coulombe","year":"2012","unstructured":"Coulombe, F. et al. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection. PLoS One. 7, e36734 (2012).","journal-title":"PLoS One."},{"key":"20686_CR33","doi-asserted-by":"crossref","unstructured":"Miteva, K. et al. Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis. Stem Cells Transl Med (2017).","DOI":"10.1002\/sctm.16-0353"},{"key":"20686_CR34","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1172\/JCI57761","volume":"121","author":"KM Davis","year":"2011","unstructured":"Davis, K. M., Nakamura, S. & Weiser, J. N. Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest. 121, 3666\u20133676 (2011).","journal-title":"J Clin Invest."},{"key":"20686_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.yjmcc.2014.07.021","volume":"76","author":"L Liu","year":"2014","unstructured":"Liu, L., Yue, Y. & Xiong, S. NK-derived IFN-gamma\/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis. J Mol Cell Cardiol. 76, 15\u201325 (2014).","journal-title":"J Mol Cell Cardiol."},{"key":"20686_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/CIRCRESAHA.109.195230","volume":"105","author":"K Li","year":"2009","unstructured":"Li, K. et al. Differential macrophage polarization in male and female BALB\/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res. 105, 353\u2013364 (2009).","journal-title":"Circ Res."},{"key":"20686_CR37","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/nm960","volume":"9","author":"U Eriksson","year":"2003","unstructured":"Eriksson, U. et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. 9, 1484\u20131490 (2003).","journal-title":"Nat Med."},{"key":"20686_CR38","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.4049\/jimmunol.138.8.2488","volume":"138","author":"N Neu","year":"1987","unstructured":"Neu, N. et al. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol. 138, 2488\u20132492 (1987).","journal-title":"J Immunol."},{"key":"20686_CR39","first-page":"566","volume":"69","author":"N Neu","year":"1987","unstructured":"Neu, N. et al. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol. 69, 566\u2013574 (1987).","journal-title":"Clin Exp Immunol."},{"key":"20686_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0735-1097(10)80331-6","volume":"16","author":"DA Neumann","year":"1990","unstructured":"Neumann, D. A. et al. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol. 16, 839\u2013846 (1990).","journal-title":"J Am Coll Cardiol."},{"key":"20686_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molmed.2010.11.001","volume":"17","author":"PJ Shaw","year":"2011","unstructured":"Shaw, P. J., McDermott, M. F. & Kanneganti, T. D. Inflammasomes and autoimmunity. Trends Mol Med. 17, 57\u201364 (2011).","journal-title":"Trends Mol Med."},{"key":"20686_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ajpath.2014.11.023","volume":"185","author":"S Ong","year":"2015","unstructured":"Ong, S. et al. Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration. Am J Pathol. 185, 847\u2013861 (2015).","journal-title":"Am J Pathol."},{"key":"20686_CR43","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/ejhf.148","volume":"16","author":"F Escher","year":"2014","unstructured":"Escher, F. et al. Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome. Eur J Heart Fail. 16, 1066\u20131072 (2014).","journal-title":"Eur J Heart Fail."},{"key":"20686_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","volume":"105","author":"A Abbate","year":"2010","unstructured":"Abbate, A. et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol. 105, 1371\u20131377 e1371 (2010).","journal-title":"Am J Cardiol."},{"key":"20686_CR45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/01.RES.75.2.245","volume":"75","author":"E Kiss","year":"1994","unstructured":"Kiss, E., Jakab, G., Kranias, E. G. & Edes, I. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res. 75, 245\u2013251 (1994).","journal-title":"Circ Res."},{"key":"20686_CR46","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","volume":"57","author":"M Kasner","year":"2011","unstructured":"Kasner, M. et al. Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol. 57, 977\u2013985 (2011).","journal-title":"J Am Coll Cardiol."},{"key":"20686_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13710","volume":"7","author":"J Yang","year":"2016","unstructured":"Yang, J. et al. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment. Nat Commun. 7, 13710 (2016).","journal-title":"Nat Commun."},{"key":"20686_CR48","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.yexcr.2008.12.022","volume":"315","author":"T Binger","year":"2009","unstructured":"Binger, T. et al. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 315, 1468\u20131479 (2009).","journal-title":"Exp Cell Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20686-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20686-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:41:27Z","timestamp":1693518087000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-20686-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["20686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-20686-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"21 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"2820"}}